A sixth dose of tetanus, diphtheria, acellular pertussis (Tdap) vaccine in adolescents might
produce a differing reactogenicity and/or immunogenicity response depending on the …

Objective. We compared the diphtheria and tetanus toxoids and bicomponent acellular
pertussis vaccine (DTaP) responses in Japanese and United States infants. Design. This …

Background: In a previous study, we found that monovalent acellular pertussis (aP) vaccine
at birth and 1 month achieves higher IgG antibody (Ab) levels to pertussis toxoid (PT) …

• An acellular pertussis-component combined diphtheria and tetanus toxoids, and pertussis
(APDT) vaccine adsorbed was compared with a licensed whole-cell pertussis-component …

CHILDHOOD immunization against diphtheria-tetanus-pertussis using an acellular pertussis
vaccine for the first three doses has moved measurably closer. Data from two large field …

• Objective—To compare the reactogenicity and immunogenicity of a diphtheria and tetanus
toxoids and two-component acellular pertussis (ADTP) vaccine with a US-licensed whole …

Background. In 1992–1993, a randomized, double-blind, placebo-controlled clinical trial of
two 3-component acellular pertussis vaccines was started in 4 of Italy's 20 regions. During …

After concern about the safety of diphtheria-tetanus toxoid-whole cell pertussis vaccines
(DTPw), the recommendation to vaccinate children with DTPw was withdrawn in 1974 in the …

The objective of this study was to evaluate reactogenicity and immunogenicity of the recently
US-licensed Connaught/BIKEN (C/B) acellular DTP (ADTP) vaccine as a booster for children …

Two acellular pertussis vaccines, one containing only LPF toxoid (25 μg) and the other
containing LPF toxoid (25 μg) and FHA (25 μg) and each combined with diphtheria and …